Abstract 1248: Predictors of innate resistance to pembrolizumab in patients with microsatellite instability-high endometrial cancer
Jeffrey How(The University of Texas MD Anderson Cancer Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Samuel C. Mok(The University of Texas MD Anderson Cancer Center), Ivo Vletic(The University of Texas MD Anderson Cancer Center), Linghua Wang(The University of Texas MD Anderson Cancer Center), Sammy Ferri‐Borgogno(The University of Texas MD Anderson Cancer Center), Minghao Dang(The University of Texas MD Anderson Cancer Center), Jared Burks(The University of Texas MD Anderson Cancer Center), Javier A. Gomez(The University of Texas MD Anderson Cancer Center), Weiyi Peng(University of Houston), Elizabeth D. Euscher(The University of Texas MD Anderson Cancer Center), Shrina Patel(The University of Texas MD Anderson Cancer Center), Karen Lu(The University of Texas MD Anderson Cancer Center), Melinda S. Yates(University of North Carolina at Chapel Hill)
Cited by 3
Related Papers
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
|Cell Reports|2018|1.3k